Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
XXII US​

22nd Century Group, Inc.(XXII US)

$0.20-0.028.34%Ext:$0.12-0.0839.00%(Market Closed · 00:00:01 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

22nd Century Group, Inc. — Company Profile

22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.

Sector
Consumer Staples
Industry
Tobacco
Exchange
UQ
CEO
Lawrence D. Firestone
Headquarters
Mocksville, IN, US
IPO Date
Jan 26, 2011
Employees
32
Website
www.xxiicentury.com

Key Metrics

Price
$0.91
Market Cap
$315.44K
Revenue (TTM)
$4.11M
Net Income (TTM)
$-3261000.00
EPS (TTM)
-18.08
P/E (TTM)
-0.08
P/B (TTM)
0.01
Dividend Yield
0.00%
ROE (TTM)
-15.37%
ROA (TTM)
-10.76%
Operating Margin
-74.03%
Beta
7.06

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.

Website
www.xxiicentury.com
Location
Mocksville, IN, US
Phone716 270 1523
Employees32
CEOLawrence D. Firestone
Sector
Consumer Staples
Industry
Tobacco
IPO DateJan 26, 2011

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

SEC Filings(875)

Expand
  • 424B5Prospectus filing (Rule 424(b)(5))23 Oct
  • 8-KOther Events23 Oct
  • 8-KResults of Operations and Financial Condition22 Oct
  • 8-KRegulation FD Disclosure1 Sep
  • SC 13G22nd Century Group, Inc.25 Aug
  • SC 13G22nd Century Group, Inc.20 Aug
  • SC 13G22nd Century Group, Inc.20 Aug
  • S-8Registration statement (employee benefit plan)14 Aug
  • 10-QQ2ended 30 Jun 202614 Aug
  • 424B3Prospectus filing (Rule 424(b)(3))14 Aug
  • SC 13G/A22nd Century Group, Inc.14 Aug
  • 8-KResults of Operations and Financial Condition13 Aug
  • 8-KSubmission of Matters to a Vote of Security Holders5 Aug
  • 8-KTermination of a Material Definitive Agreement2 Jul
  • 424B3Prospectus filing (Rule 424(b)(3))26 Jun
  • EFFECTNotice of effectiveness25 Jun
  • DEF 14ADefinitive proxy statement23 Jun
  • PRE 14APreliminary proxy statement12 Jun
  • S-3Registration statement (primary offering)12 Jun
  • 8-KSubmission of Matters to a Vote of Security Holders11 Jun

News

  • 22nd Century Group Preliminarily Reports Third Quarter Financial Results22 Oct
  • 22nd Century Same Store Unit Sales for Pinnacle VLN® and Pinnacle Pure Surge 161%15 Oct
  • 22nd Century Group's Reduced-Nicotine Tobacco Platform Positioned to Support France's Nicotine-Reduction Initiative28 Sep
  • 22nd Century Group Urges Policymakers and FDA to Enact and Implement the Reduced Nicotine Content Standard, Citing Years Without a Final Rule24 Sep
  • 22nd Century CEO & Chairman Larry Firestone: Improved Gross Margin, ~5,000 Retail Outlets and >$50B Market Opportunity Highlight Mid-Year Stockholder Letter1 Sep
  • 22nd Century Group to Participate in the HC Wainwright Conference on September 15, 202618 Aug
  • 22nd Century Group, Inc. (XXII) Q2 2026 Earnings Call Prepared Remarks Transcript13 Aug
  • 22nd Century Group Reports Second Quarter 2026 Financial Results13 Aug
  • 22nd Century Group to Announce Second Quarter 2026 Results on August 13, 20264 Aug

Mentions in Filings

  • … ector Tobacco’s *QUEST 3* brand have provided the scientific basis for the FDA’s proposed rule to reduce the addictiveness of cigarettes discussed above. SPECTRUM® research cigarettes are owned, produced and sold by <strong>22nd Century Group</strong>, Inc, which is unrelated to the Company. As outlined by the FDA, “A Modified Risk Tobacco Product (MRTP) application can be submitted by any person for a proposed MRTP seeking an FDA modified risk order, under sect …
    Cabbacis Inc22nd Century Group, Inc.·PART II AND III - 1-A POS - POST-QUALIFICATION AMENDMENT NO. 5 TO FORM 1-A·Q4 26·19 Oct
  • … oard member for its IKE Joint Venture and has served in this capacity since April 2024. From July 2020 to April 2023, Mr. Przybyla was General Counsel and Corporate Secretary, and then President of Hemp/Cannabis, at <strong>22nd Century Group</strong>. Inc., a plant biotechnology company. While at 22nd Century, Mr. Przybyla helped to secure the only Modified Risk Tobacco Product approval for a combustible cigarette authorized by the U.S. Food and Drug Administrat …
    Ispire Technology Inc.22nd Century Group, Inc.·10-K - ANNUAL REPORT FY 2026·FY26·15 Sep
  • … ompany’s appointed board member for its IKE Joint Venture from April 2024 to July 2026. From July 2020 to April 2023, Mr. Przybyla was General Counsel and Corporate Secretary, and then President of Hemp/Cannabis, at <strong>22nd Century Group</strong>. Inc., a plant biotechnology company. While at 22nd Century, Mr. Przybyla helped to secure the only Modified Risk Tobacco Product approval for a combustible cigarette authorized by the U.S. Food and Drug Administrat …
    Ispire Technology Inc.22nd Century Group, Inc.·8-K - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers·Q1 27·17 Aug
  • … arkets. Mr. Przybyla remains the corporate secretary for IKE Tech. From July 2020 to April 2023, Mr. Przybyla served as General Counsel and Corporate Secretary, and subsequently as President of Hemp/Cannabis, at <strong>22nd Century Group, Inc.</strong>, a plant biotechnology company, where he helped secure the only Modified Risk Tobacco Product authorization for a combustible cigarette granted by the U.S. Food and Drug Administration to date. Previously, he was …
    Ispire Technology Inc.22nd Century Group, Inc.·EX-99.1 - 8-K - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers·Q1 27·17 Aug
  • … erve as the Company’s President. Mr. Sicignano was appointed as President of the Company on April 1, 2021. Prior to joining the Company, Mr. Sicignano held multiple positions, including Chief Executive Officer of <strong>22nd Century Group, Inc.</strong> (NASDAQ: XXII), a plant-based biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research from March 2015 through July 2019. He also served as Pr …
    Charlie's Holdings, Inc.22nd Century Group, Inc.·8-K - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers·Q3 26·4 Aug
  • … oard member for its IKE Joint Venture and has served in this capacity since April 2024. From July 2020 to April 2023, Mr. Przybyla was General Counsel and Corporate Secretary, and then President of Hemp/Cannabis, at <strong>22nd Century Group</strong>. Inc., a plant biotechnology company. While at 22nd Century, Mr. Przybyla helped to secure the only Modified Risk Tobacco Product approval for a combustible cigarette authorized by the U.S. Food and Drug Administrat …
    Ispire Technology Inc.22nd Century Group, Inc.·DEF 14A - PROXY STATEMENT·Q4 26·12 May

Key Stats

Trading

Px/Chg 1D$0.91 / +7.78%
Avg Volume927.32K
Beta7.06
Mkt Cap315.44K
FD Mkt Cap1.10M

Float

Shrs Out/Float345.12K / 188.21K
Short Float0.07%
Days to Cover1.00
Stock Repurchased$9.65M

Current Valuation

EV-7913556.66
EV/EBITDA0.73
EV/Sales-0.89
P/B0.01
P/S0.04
FCF Yield-996.38%
ROE-15.37%
ROA-10.76%
Current Ratio2.67

Estimates

P/E-0.08
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgMay '23May '24May '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-0.54-2.44-0.01-0.01-0.14-0.10
Price / Sales0.833.610.060.010.380.08
Price / Book Value0.271.52-0.230.040.030.01
Price / Free Cash Flow-0.52-2.60-0.03-0.010.15-0.10
ENTERPRISE VALUE METRICS
Enterprise Value31.8148.616.34.4-2.5-7.9
Enterprise Value / Sales0.043.670.510.37-2.42-1.93
Enterprise Value / EBITDA-0.28-4.52-0.40-0.361.012.87
Enterprise Value / EBIT-0.24-4.07-0.36-0.330.922.63

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue-30.9%30.940.532.211.97.0
Gross Income—1.51.8-8.7-2.4-3.1
EBITDA-23.7%-31.0-32.9-40.4-12.1-10.5
EBIT-22.6%-32.5-36.5-45.3-13.4-11.7
Net Income-37.3%-32.6-59.8-140.8-15.2-5.1
EPS (Diluted)-93.1%-2,333,407.00-51,995,584.00-5,424,728.00-60,017.00-52.88
BALANCE SHEET
Cash & ST Inv-38.1%48.720.42.14.47.1
Total Assets-22.8%76.0114.727.521.727.0
Total Liabilities3.3%9.918.735.917.711.3
Total Shareholder Equity-30.1%66.196.0-8.44.015.8
CASH FLOW
Net Operating Cash Flow-23.7%-22.8-51.7-55.0-14.3-7.7
Cap Ex-4.9%-1.1-4.4-5.6-0.2-0.9
Free Cash Flow-22.6%-23.9-56.1-60.6-14.5-8.6

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)0.19
Basic Shares0.35
Market Cap0.1
Diluted Shares0.60
Fully Diluted Shares Outstanding0.60
Fully Diluted Market Cap0.1
+Consolidated Debt1.3
−In-the-Money Convertible Debt—
+Capital Leases0.6
+Operating Leases—
−Cash & Equivalents-9.5
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value-8.2

Segment data

Revenue

by Products and services

  • Contract Manufacturing50%
  • Cigarettes37%
  • Filtered Cigars12%
  • Other Tobacco Products1%

Related companies

Altria Group, Inc.

MO US

RLX Technology Inc.

RLX US

White Fox Ventures, Inc.

AWAW US

BOTS, Inc./PR

BTZI US

Omni Health, Inc.

OMHE US

ML Capital Group, Inc.

MLCG US

Philip Morris International Inc.

PM US

British American Tobacco p.l.c.

BTAFF US